FILTER
Refine your search with the following facets to narrow down your results.
- reductions 3
- Altana 2
- Alzheimer's disease 2
- GSK 2
- Norway 2
- Pharmacia 2
- anti-inflammatory drugs 2
- chemicals 2
- chemistry 2
- clinical trials 2
- diseases 2
- flow 2
- inflammation 2
- lung diseases 2
- medicine 2
- obesity 2
- oncology 2
- regulatory approval 2
- rheumatoid arthritis 2
- schizophrenia 2
- services 2
- synthesis 2
- AIDS 1
- AstraZeneca 1
- Bayer 1
- Bristol-Myers Squibb 1
- CAS 1
- CNS disorders 1
- Eli Lilly 1
- General Electric 1
- Germany 1
- Greenhouse Gases 1
- HIV 1
- Iceland 1
- Ireland 1
- Japan 1
- Martin’s Sulfurane 1
- Mosher’s Acid 1
- Novartis 1
- Ohira-Bestmann Reagent 1
- Reissert Compound 1
- Sanofi-aventis 1
- Siemens 1
- active pharmaceutical ingredients 1
- additives 1
- allergies 1
- anti-infectives 1
- antibodies 1
- apoptosis 1
- arthritis 1
- autoimmune diseases 1
- calcium 1
- catalysis 1
- celecoxib 1
- central nervous system 1
- chemical engineering 1
- climate change 1
- compliance 1
- computational chemistry 1
- diabetes 1
- diagnostics 1
- diarrhea 1
- dosing 1
- drug screening 1
- emissions 1
- epirubicin 1
- evolution 1
- fat storage 1
- fungal infections 1
- generics 1
- glucose 1
- heating 1
- hepatitis C 1
- insulin 1
- intermediates 1
- license agreements 1
- lung function 1
- memory 1
- milestone payments 1
- mills 1
- nitrogen 1
- osteoarthritis 1
- oxytetracycline 1
- pain 1
- patent litigations 1
- patents 1
- peptides 1
- phase I studies 1
- positron emission tomography 1
- process analysis 1
- process development 1
- proteases 1
- pulmonary diseases 1
- raw materials 1
- sodium 1
- Pfizer Inc. 32
- ALTANA AG 2
- Vicuron Pharmaceuticals Inc. 2
- Accelrys, Inc. 1
- Agency for Science, Technology and Research (A*STAR) 1
- AstraZeneca PLC 1
- BioRexis Pharmaceutical Corporation 1
- Bristol-Myers Squibb Co. 1
- Coley Pharmaceutical Group 1
- Eli Lilly and Company 1
- Environmental Protection Agency (EPA) 1
- Glaxo Wellcome GmbH & Co. 1
- GlaxoSmithKline plc (GSK) 1
- Hikal Ltd. 1
- Idun Pharmaceuticals Inc. 1
- Institute of Chemical and Engineering Sciences (ICES) 1
- Johnson & Johnson 1
- National Institute of General Medical Sciences (NIGMS) 1
- Pfizer Pharma GmbH 1
- Ranbaxy Laboratories Ltd. 1
- Siemens AG 1
- Society of Chemical Industry (SCI) 1
- Symbion Health Limited 1
- Taisho Pharmaceutical Co., Ltd. 1
- Tripos, Inc. 1
- Vanderbilt University 1
- Yale University 1
- sanofi-aventis Groupe 1
33 Current news of Pfizer
FILTERS
Refine your search with the following facets to narrow down your results.
- reductions 3
- Altana 2
- Alzheimer's disease 2
- GSK 2
- Norway 2
- Pharmacia 2
- anti-inflammatory drugs 2
- chemicals 2
- chemistry 2
- clinical trials 2
- diseases 2
- flow 2
- inflammation 2
- lung diseases 2
- medicine 2
- obesity 2
- oncology 2
- regulatory approval 2
- rheumatoid arthritis 2
- schizophrenia 2
- services 2
- synthesis 2
- AIDS 1
- AstraZeneca 1
- Bayer 1
- Bristol-Myers Squibb 1
- CAS 1
- CNS disorders 1
- Eli Lilly 1
- General Electric 1
- Germany 1
- Greenhouse Gases 1
- HIV 1
- Iceland 1
- Ireland 1
- Japan 1
- Martin’s Sulfurane 1
- Mosher’s Acid 1
- Novartis 1
- Ohira-Bestmann Reagent 1
- Reissert Compound 1
- Sanofi-aventis 1
- Siemens 1
- active pharmaceutical ingredients 1
- additives 1
- allergies 1
- anti-infectives 1
- antibodies 1
- apoptosis 1
- arthritis 1
- autoimmune diseases 1
- calcium 1
- catalysis 1
- celecoxib 1
- central nervous system 1
- chemical engineering 1
- climate change 1
- compliance 1
- computational chemistry 1
- diabetes 1
- diagnostics 1
- diarrhea 1
- dosing 1
- drug screening 1
- emissions 1
- epirubicin 1
- evolution 1
- fat storage 1
- fungal infections 1
- generics 1
- glucose 1
- heating 1
- hepatitis C 1
- insulin 1
- intermediates 1
- license agreements 1
- lung function 1
- memory 1
- milestone payments 1
- mills 1
- nitrogen 1
- osteoarthritis 1
- oxytetracycline 1
- pain 1
- patent litigations 1
- patents 1
- peptides 1
- phase I studies 1
- positron emission tomography 1
- process analysis 1
- process development 1
- proteases 1
- pulmonary diseases 1
- raw materials 1
- sodium 1
- Pfizer Inc. 32
- ALTANA AG 2
- Vicuron Pharmaceuticals Inc. 2
- Accelrys, Inc. 1
- Agency for Science, Technology and Research (A*STAR) 1
- AstraZeneca PLC 1
- BioRexis Pharmaceutical Corporation 1
- Bristol-Myers Squibb Co. 1
- Coley Pharmaceutical Group 1
- Eli Lilly and Company 1
- Environmental Protection Agency (EPA) 1
- Glaxo Wellcome GmbH & Co. 1
- GlaxoSmithKline plc (GSK) 1
- Hikal Ltd. 1
- Idun Pharmaceuticals Inc. 1
- Institute of Chemical and Engineering Sciences (ICES) 1
- Johnson & Johnson 1
- National Institute of General Medical Sciences (NIGMS) 1
- Pfizer Pharma GmbH 1
- Ranbaxy Laboratories Ltd. 1
- Siemens AG 1
- Society of Chemical Industry (SCI) 1
- Symbion Health Limited 1
- Taisho Pharmaceutical Co., Ltd. 1
- Tripos, Inc. 1
- Vanderbilt University 1
- Yale University 1
- sanofi-aventis Groupe 1